Get the Stockscreener App
4.09
0.49%
0.02
After Hours:
4.09
Clearside Biomedical Inc stock is traded at $4.09, with a volume of 86,791.
It is up +0.49% in the last 24 hours and down -6.41% over the past month.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
See More
Previous Close:
$4.07
Open:
$4.04
24h Volume:
86,791
Relative Volume:
1.78
Market Cap:
$21.30M
Revenue:
$4.17M
Net Income/Loss:
$-27.71M
P/E Ratio:
-11.05
EPS:
-0.37
Net Cash Flow:
$-22.23M
1W Performance:
+5.41%
1M Performance:
-6.41%
6M Performance:
-68.65%
1Y Performance:
-73.00%
1-Day Range:
$3.875
$4.17
1-Week Range:
$3.61
$4.17
52-Week Range:
$3.32
$17.40
Clearside Biomedical Inc Stock (CLSD) Company Profile
Name
Clearside Biomedical Inc
Sector
Industry
Phone
678-270-3631
Address
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
4.09 | 21.30M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-18-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-25 | Downgrade | Stifel | Buy → Hold |
| Aug-21-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Dec-15-21 | Resumed | Wedbush | Outperform |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| May-13-20 | Initiated | ROTH Capital | Buy |
| Aug-09-19 | Downgrade | Needham | Buy → Hold |
| Nov-05-18 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-05-18 | Downgrade | JP Morgan | Overweight → Underweight |
| Nov-05-18 | Downgrade | Stifel | Buy → Hold |
| Mar-06-18 | Reiterated | Needham | Buy |
| May-25-17 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-17 | Initiated | JP Morgan | Overweight |
| Nov-10-16 | Reiterated | Needham | Buy |
| Oct-24-16 | Reiterated | Stifel | Buy |
View All
Clearside Biomedical Inc Stock (CLSD) Latest News
What moving averages say about Clearside Biomedical Inc.Weekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
Will Clearside Biomedical Inc. stock benefit from automation2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
How sentiment analysis helps forecast Clearside Biomedical Inc.Oil Prices & Community Verified Trade Signals - newser.com
How Clearside Biomedical Inc. (CLM) stock performs in volatility spikesJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Should you hold or exit Clearside Biomedical Inc. nowStop Loss & Daily Chart Pattern Signal Reports - newser.com
Should I buy Clearside Biomedical Inc. (CLM) stock before earnings season2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Risk adjusted return profile for Clearside Biomedical Inc. analyzedPortfolio Profit Report & Precise Swing Trade Alerts - newser.com
Clearside Biomedical Inc. recovery potential after sell offRate Hike & Verified Momentum Stock Watchlist - newser.com
Does Clearside Biomedical Inc. qualify in momentum factor screeningQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
How strong is Clearside Biomedical Inc. stock balance sheetTrade Ideas & Weekly Top Gainers Trade List - newser.com
Clearside Biomedical Inc. stock daily chart insights2025 Dividend Review & Accurate Buy Signal Alerts - newser.com
What recovery options are there for Clearside Biomedical Inc.July 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Will Clearside Biomedical Inc. price bounce be sustainableJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Order flow analysis tools used on Clearside Biomedical Inc.2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-11-02 02:43:28 - newser.com
How Clearside Biomedical Inc. stock performs in interest rate cycles2025 Technical Overview & Stock Timing and Entry Methods - newser.com
Is Clearside Biomedical Inc. still worth holding after the dipSell Signal & Technical Pattern Recognition Alerts - newser.com
Short interest data insights for Clearside Biomedical Inc.July 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Historical volatility pattern of Clearside Biomedical Inc. visualizedJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Published on: 2025-10-31 03:40:30 - newser.com
How Clearside Biomedical Inc. stock compares to industry benchmarksWeekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Will Clearside Biomedical Inc. stock see PE expansionWeekly Market Summary & Real-Time Market Sentiment Reports - newser.com
How Clearside Biomedical Inc. (CLM) stock performs in easing cyclesTrade Ideas & Fast Moving Stock Watchlists - newser.com
Clearside Biomedical Inc Stock (CLSD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):